JP2019064597A - Chemical volatilizer - Google Patents
Chemical volatilizer Download PDFInfo
- Publication number
- JP2019064597A JP2019064597A JP2017188431A JP2017188431A JP2019064597A JP 2019064597 A JP2019064597 A JP 2019064597A JP 2017188431 A JP2017188431 A JP 2017188431A JP 2017188431 A JP2017188431 A JP 2017188431A JP 2019064597 A JP2019064597 A JP 2019064597A
- Authority
- JP
- Japan
- Prior art keywords
- opening
- drug
- space
- case
- cylindrical wall
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- QBEXCTSMXLOGSB-UHFFFAOYSA-N C1C2=C1CCC2 Chemical compound C1C2=C1CCC2 QBEXCTSMXLOGSB-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Catching Or Destruction (AREA)
- Packaging Of Annular Or Rod-Shaped Articles, Wearing Apparel, Cassettes, Or The Like (AREA)
- Disinfection, Sterilisation Or Deodorisation Of Air (AREA)
Abstract
Description
本発明は、例えば、芳香剤、消臭剤、防虫剤などの薬剤を揮散させるための薬剤揮散具に関する。 The present invention relates to a drug volatilization tool for volatilizing a drug such as, for example, an aromatic agent, a deodorant, an insect repellent and the like.
芳香剤などの揮発性を有する薬剤は、空気に触れることで揮散を開始する。このため、例えば、従来の薬剤揮散具においては、芳香剤を収容した容器の開口部をシールしておき、使用開始時にシールを破るようにしている。 Volatile agents such as fragrances start volatilization when exposed to air. Therefore, for example, in the conventional drug volatilization device, the opening of the container containing the fragrance is sealed, and the seal is broken at the start of use.
例えば、特許文献１の芳香剤容器は、芳香剤を収納した収納容器体、および収納容器体を装着するケース体を有する。この芳香剤容器の使用を開始するときには、収納容器体をケース体に装着することで、収納容器体の開口部を密閉したシート蓋を破断する。これにより、収納容器体に収納した芳香剤をケース体の気散シートに浸透させて気散シートから芳香剤を放散させる。よって、特許文献１の芳香剤容器によると、シート蓋を簡単に開封することができ、芳香剤をすぐに揮散させることができる。 For example, the fragrance container of Patent Document 1 has a storage container body containing a fragrance and a case body for mounting the storage container body. When the use of the fragrance container is started, the storage container body is attached to the case body, and the sheet lid sealing the opening of the storage container body is broken. Thereby, the fragrance stored in the storage container body is made to penetrate the air diffusion sheet of the case body, and the air diffusion sheet is made to dissipate the fragrance. Therefore, according to the fragrance container of Patent Document 1, the sheet lid can be easily opened, and the fragrance can be volatilized immediately.
しかし、特許文献１の芳香剤容器によると、収納容器体に挿通した浸透芯を通して芳香剤を気散シートに浸透させるため、シート蓋の開封後は、芳香剤が一定の割合で空気中に放散され続け、芳香剤の放散をコントロールすることができない。 However, according to the fragrance container of Patent Document 1, in order to allow the fragrance sheet to penetrate the air diffusion sheet through the penetration core inserted into the storage container body, after the sheet lid is opened, the fragrance is dissipated in the air at a constant rate. Continues to be able to control the emission of fragrance.
本発明は、上記の点に鑑みてなされたもので、薬剤を所望する状態で揮散させることができる薬剤揮散具を提供することを目的とする。 The present invention has been made in view of the above-mentioned point, and an object of the present invention is to provide a drug volatilization device capable of volatilizing a drug in a desired state.
本発明の薬剤揮散具の一態様は、揮発性を有する薬剤を担持した薬剤担持体を収容した第１の空間、および第１の空間を開放する第１の開口部を有する第１の収容部と、第１の収容部の第１の開口部を封止して第１の空間を密封した密封材と、薬剤担持体を受け入れ可能な第２の空間、第２の空間を第１の収容部の第１の空間に連通させるための第２の開口部、第２の開口部に設けられ第２の開口部を第１の開口部に重ねたときに第１の開口部の内側に挿通されて密封材を破る破封部、および第２の空間を外気に連通させるための揮散孔を有する第２の収容部と、を有する。 One aspect of the drug volatilization device of the present invention is a first container containing a first space containing a drug carrier carrying a drug having a volatile property, and a first opening for opening the first space. A sealing material for sealing the first space by sealing the first opening of the first housing, a second space capable of receiving the drug carrier, and a second space for the second space A second opening for communicating with the first space of the part, and a second opening provided in the second opening is inserted inside the first opening when the second opening is overlapped with the first opening And a second housing portion having a vaporization hole for communicating the second space with the outside air.
本発明の一態様によれば、薬剤を所望する状態で揮散させることができる薬剤揮散具を提供することができる。 According to one aspect of the present invention, it is possible to provide a drug volatilizer capable of volatilizing a drug in a desired state.
以下、本発明の実施形態について図面を参照して説明する。
（第１の実施形態）
図１に示すように、第１の実施形態に係る薬剤揮散具１０は、略球形の２つの容器２、４を環状のゴム紐６でつないだ構造を有する。ゴム紐６は、必ずしも環状である必要はなく１本の紐状部材であってもよく、必ずしも伸縮可能な材料により形成しなくてもよい。
Hereinafter, embodiments of the present invention will be described with reference to the drawings.
First Embodiment
As shown in FIG. 1, the drug volatilization device 10 according to the first embodiment has a structure in which two substantially spherical containers 2 and 4 are connected by an annular rubber string 6. The rubber cord 6 does not have to be annular, and may be a single cord-like member, and may not necessarily be made of an expandable material.
一方の容器２の中には、揮発性を有する薬剤（芳香剤や消臭剤など）を封入したマイクロカプセルを担持した複数個の粒状の薬剤担持体（ここでは図示せず）が収容されている。薬剤担持体は、マイクロカプセルを用いずに薬剤を粒状の担持体に直接担持させたものであってもよく、薬剤自体を固まりにした粒状のものも薬剤担持体に含むものとする。薬剤担持体の個数、形状、大きさは、任意に設定可能であり、容器２に振動を与えたときに容器２内で移動可能であればよい。 In one container 2, a plurality of granular drug carriers (not shown here) carrying microcapsules in which a volatile drug (a fragrance, a deodorant, etc.) is sealed are contained. There is. The drug carrier may be one in which the drug is directly carried on a particulate carrier without using microcapsules, and the drug carrier includes particles in which the drug itself is solidified. The number, shape, and size of the drug carriers can be set arbitrarily, as long as they can move within the container 2 when the container 2 is vibrated.
もう一方の容器４は、容器２と同じように薬剤担持体を収容してもよく、薬剤担持体を収容しなくてもよい。２つの容器２、４の大きさや形状も同じである必要はない。容器４は、内部を空洞にする必要もない。しかし、本実施形態では、容器４を容器２と同じ構造に形成し、内部に薬剤担持体を収容した。以下の説明では、一方の容器２の構造について詳細に説明し、他方の容器４の構造については、容器２と同様に機能する構成要素に同一符号を付してその詳細な説明を省略する。 The other container 4 may contain the drug carrier in the same manner as the container 2 and may not contain the drug carrier. The size and shape of the two containers 2 and 4 do not have to be the same. The container 4 does not have to be hollow inside. However, in the present embodiment, the container 4 is formed in the same structure as the container 2, and the drug carrier is accommodated inside. In the following description, the structure of one container 2 will be described in detail, and as for the structure of the other container 4, components that function in the same manner as the container 2 will be assigned the same reference numerals and detailed description thereof will be omitted.
上記の構造を有する薬剤揮散具１０は、例えば、図２に示すように、自動車のヘッドレスト１２に結び付けたり、バックミラーに括り付けたり、エアコンの吹き出し口にあるルーバーに引っ掛けて取り付けたり、後部座席の上方にあるアシストグリップに結び付けたりして使用することができる。薬剤揮散具１０は、自動車の構成部品以外のいかなる吊り下げ対象物にも取り付けできる。 For example, as shown in FIG. 2, the drug volatilization tool 10 having the above-described structure may be tied to a headrest 12 of an automobile, tied to a rearview mirror, hooked and attached to a louver at an air outlet, or rear seat It can be used by tying it to the assist grip located above. The chemical volatilizer 10 can be attached to any suspended object other than the component parts of the vehicle.
薬剤揮散具１０を例えば自動車の座席のヘッドレスト１２に結び付ける場合、ゴム紐６をヘッドレスト１２の一方の支柱１２ａに結び付ける。本実施形態の薬剤揮散具１０は、容器２に振動を与えることで、薬剤担持体に担持したマイクロカプセルが破袋して薬剤が揮散するものであるため、自動車などの移動体に取り付けて使用するのに適している。例えば、薬剤揮散具１０を自動車に取り付けると、自動車を運転しているときに芳香剤の揮散量を増加させ、駐車しているときには揮散量を抑制することができ、所望するタイミングで芳香剤の揮散量を増加させることができる。 When the drug volatilization tool 10 is tied to, for example, the headrest 12 of a car seat, the rubber strap 6 is tied to one of the columns 12 a of the headrest 12. The drug volatilization tool 10 of the present embodiment is used by attaching it to a mobile body such as an automobile because the microcapsules carried on the drug carrier are broken and the drug volatilizes by giving vibration to the container 2. It is suitable for For example, when the drug volatilization tool 10 is attached to a car, the volatilization amount of the fragrance can be increased when the car is driven, and the volatilization amount can be suppressed when the car is parked. The amount of volatilization can be increased.
以下、容器２の構造について、図３乃至図６を参照して説明する。
容器２は、略半球状の２つの樹脂ケース２ａ、２ｂを略矩形板状の可撓性を有する連結部材８を介して一体に連結した構造を有する。本実施形態では、樹脂ケース２ａ、２ｂ、および連結部材８は、樹脂による一体成形により形成されている。容器２は、図３に示すように、各樹脂ケース２ａ、２ｂの開口部の縁を互いに嵌め合わせた構造を有し、内部に薬剤担持体を収容するための概ね円筒状の収容空間１（図６）を有する。
Hereinafter, the structure of the container 2 will be described with reference to FIGS. 3 to 6.
The container 2 has a structure in which two substantially hemispherical resin cases 2 a and 2 b are integrally connected via a substantially rectangular plate-like flexible connection member 8. In the present embodiment, the resin cases 2a and 2b and the connecting member 8 are formed by integral molding of a resin. As shown in FIG. 3, the container 2 has a structure in which the edges of the openings of the resin cases 2 a and 2 b are fitted to each other, and a substantially cylindrical accommodation space 1 for accommodating the drug carrier therein ( 6).
一方の樹脂ケース２ａの内面には、それぞれ嵌合穴３ａを有する３つのボス部３が一体に設けられている。もう一方の樹脂ケース２ｂの対応する部位には、樹脂ケース２ａの各ボス部３の嵌合穴３ａにそれぞれ嵌合する３本の嵌合ピン５が一体に設けられている。２つの樹脂ケース２ａ、２ｂを嵌合させる際には、連結部材８を湾曲させつつ２つの樹脂ケース２ａ、２ｂの開口部を対向させ、樹脂ケース２ａの各嵌合穴３ａに樹脂ケース２ｂの各嵌合ピン５を押し込む。連結部材８は、図３に示すように環状に湾曲されてゴム紐６を挿通する挿通部として機能する。 Three bosses 3 each having a fitting hole 3a are integrally provided on the inner surface of one resin case 2a. Three fitting pins 5 respectively fitted in the fitting holes 3a of the bosses 3 of the resin case 2a are integrally provided at corresponding portions of the other resin case 2b. When fitting the two resin cases 2a and 2b, the opening portions of the two resin cases 2a and 2b are opposed to each other while curving the connecting member 8, and each fitting hole 3a of the resin case 2a is made of the resin case 2b. Push each fitting pin 5 into place. The connecting member 8 is curved in an annular shape as shown in FIG. 3 and functions as an insertion portion through which the rubber cord 6 is inserted.
樹脂ケース２ｂは、複数個（本実施形態では８個）の例えば円形の揮散孔２ｃを有する。揮散孔２ｃは、樹脂ケース２ｂを貫通して収容空間１に連通する位置に設けられている。つまり、揮散孔２ｃは、後述する円筒壁１６の内側の収容空間１ｂの底に設けられている。そして、揮散孔２ｃの形状や大きさは、薬剤担持体が通過できない形状や大きさに設計されている。この条件を満たせば、揮散孔２ｃの個数、形状、大きさは、任意に設定可能である。 The resin case 2 b has a plurality of (eight in the present embodiment), for example, circular volatilization holes 2 c. The volatilization hole 2 c is provided at a position which penetrates the resin case 2 b and communicates with the accommodation space 1. That is, the volatilization hole 2c is provided in the bottom of the accommodation space 1b inside the cylindrical wall 16 mentioned later. And the shape and size of the volatilization hole 2c are designed to the shape and size which can not pass a medicine carrier. If this condition is satisfied, the number, shape, and size of the volatilization holes 2c can be set arbitrarily.
図４および図５に示すように、樹脂ケース２ａは、内部に円筒壁１４を有する。また、樹脂ケース２ｂは、内部に円筒壁１６（筒状体）を有する。円筒壁１６の外径は、円筒壁１４の内径よりわずかに小さい。円筒壁１６の高さは円筒壁１４より低い。これら２つの円筒壁１４、１６は、図６に示すように２つの樹脂ケース２ａ、２ｂを嵌合させた状態で、同軸に配置される。また、樹脂ケース２ａ、２ｂを嵌合させると、円筒壁１４の内側に円筒壁１６の先端がわずかに差し込まれて、略円筒状の収容空間１が形成される。 As shown in FIGS. 4 and 5, the resin case 2a has a cylindrical wall 14 inside. Further, the resin case 2 b has a cylindrical wall 16 (cylindrical body) inside. The outer diameter of the cylindrical wall 16 is slightly smaller than the inner diameter of the cylindrical wall 14. The height of the cylindrical wall 16 is lower than that of the cylindrical wall 14. These two cylindrical walls 14 and 16 are coaxially arranged in a state in which the two resin cases 2a and 2b are fitted as shown in FIG. When the resin cases 2a and 2b are fitted, the tip of the cylindrical wall 16 is slightly inserted into the cylindrical wall 14 to form the substantially cylindrical housing space 1.
樹脂ケース２ａ内に設けた円筒壁１４は、樹脂ケース２ａの開口部を超えて突出した先端を有する。円筒壁１４の先端には、円形の開口部１４ａ（第１の開口部）が設けられている。開口部１４ａは、円筒壁１６の先端を受け入れるとともに、薬剤担持体Ｂを挿入するための開口部として機能する。円筒壁１４の内部は、予め決められた個数の薬剤担持体Ｂを収容することが可能な容積を有する収容空間１ａ（第１の空間）として機能する。円筒壁１４は、使用開始前の薬剤担持体Ｂを収容する第１の収容部として機能する。 The cylindrical wall 14 provided in the resin case 2a has a tip protruding beyond the opening of the resin case 2a. A circular opening 14 a (first opening) is provided at the tip of the cylindrical wall 14. The opening 14 a functions as an opening for receiving the distal end of the cylindrical wall 16 and for inserting the drug carrier B. The inside of the cylindrical wall 14 functions as a storage space 1a (first space) having a volume capable of storing a predetermined number of drug carriers B. The cylindrical wall 14 functions as a first accommodating portion for accommodating the drug carrier B before the start of use.
円筒壁１４の開口部１４ａは、図５に示すように開口部１４ａを介して所定数の薬剤担持体Ｂを収容した後、図４に示すように略円形の密封シート１８（密封材）でシールされる。密封シート１８は、薬剤非透過性の可撓性を有する樹脂フィルムなどで形成され、開口部１４ａの周りで円筒壁１４の先端に密着され、開口部１４ａを封止する。円筒壁１４が樹脂ケース２ａの内部に設けられているため、密封シート１８は容器２の外から見えない。このため、見栄えを気にすることなく、円筒壁１４の側面まで密封シート１８を被せてしっかりと密着させることができる。 The opening 14a of the cylindrical wall 14 accommodates a predetermined number of drug carriers B via the opening 14a as shown in FIG. 5, and then uses a substantially circular sealing sheet 18 (sealing material) as shown in FIG. Be sealed. The sealing sheet 18 is formed of a drug-impermeable resin film or the like having flexibility and is in close contact with the tip of the cylindrical wall 14 around the opening 14a to seal the opening 14a. The sealing sheet 18 can not be seen from the outside of the container 2 because the cylindrical wall 14 is provided inside the resin case 2 a. For this reason, the sealing sheet 18 can be covered and firmly attached to the side surface of the cylindrical wall 14 without worrying about the appearance.
本実施形態では、円筒壁１４の先端を樹脂ケース２ａの開口部から突出させたため、収容空間１ａの容積を比較的大きくすることができ、収容空間１ａに収容する薬剤担持体Ｂの個数を多くすることができる。円筒壁１４の径や高さは、連結部材８を中心にして樹脂ケース２ｂを樹脂ケース２ａに向けて回動させたときに円筒壁１６をスムーズに挿入できる（２つの樹脂ケース２ａ、２ｂを嵌合できる）値であればよく、薬剤担持体Ｂの収容数を多くするためできるだけ大きくすることが望ましい。 In this embodiment, since the tip of the cylindrical wall 14 protrudes from the opening of the resin case 2a, the volume of the storage space 1a can be made relatively large, and the number of drug carriers B stored in the storage space 1a is large. can do. The diameter and height of the cylindrical wall 14 allow smooth insertion of the cylindrical wall 16 when the resin case 2b is turned toward the resin case 2a about the connection member 8 (two resin cases 2a and 2b It may be any value that can be fitted, and in order to increase the number of stored drug carriers B, it is desirable to increase as much as possible.
もう一方の樹脂ケース２ｂ内に設けた円筒壁１６は、その先端に開口部１６ａ（第２の開口部）を有するとともに、開口部１６ａの縁に沿って円筒壁１６を軸方向に延長させた３つの破封爪１７（破封部、突起）を備えている。３つの破封爪１７は、開口部１６ａの周方向に沿って等間隔で設けられている。 The cylindrical wall 16 provided in the other resin case 2b has an opening 16a (second opening) at its tip, and the cylindrical wall 16 is axially extended along the edge of the opening 16a. It has three tearing claws 17 (tearings, projections). The three tearing claws 17 are provided at equal intervals along the circumferential direction of the opening 16a.
３つの破封爪１７は、２つの樹脂ケース２ａ、２ｂを嵌合させることで、密封シート１８を破封する。つまり、２つの樹脂ケース２ａ、２ｂを嵌合させると、樹脂ケース２ａの円筒壁１４の開口部１４ａを介して樹脂ケース２ｂの円筒壁１６の先端が挿入され、３つの破封爪１７が円筒壁１４の内面に沿って差し込まれる。これにより、円筒壁１４の開口部１４ａを密封した密封シート１８が破封爪１７によって少なくとも部分的に破られる。 The three seal claws 17 seal the sealing sheet 18 by fitting the two resin cases 2a and 2b. That is, when the two resin cases 2a and 2b are fitted, the tip of the cylindrical wall 16 of the resin case 2b is inserted through the opening 14a of the cylindrical wall 14 of the resin case 2a, and the three tearing claws 17 are cylindrical It is inserted along the inner surface of the wall 14. As a result, the sealing sheet 18 sealing the opening 14 a of the cylindrical wall 14 is at least partially broken by the tear-off claw 17.
樹脂ケース２ｂの円筒壁１６は、その内部に薬剤担持体Ｂを受け入れ可能な円筒状の収容空間１ｂ（第２の空間）を有する。つまり、円筒壁１６は、開口部１６ａを介して円筒壁１４から薬剤担持体Ｂを受け入れることが可能な第２の収容部として機能する。 The cylindrical wall 16 of the resin case 2b has a cylindrical housing space 1b (second space) capable of receiving the drug carrier B in its inside. That is, the cylindrical wall 16 functions as a second accommodating portion capable of receiving the drug carrier B from the cylindrical wall 14 through the opening 16a.
上述したように、破封爪１７によって少なくとも部分的に破られた密封シート１８は、収容空間１ａ内の薬剤担持体Ｂによって押圧されることで、図６に示すように大きく破られる。これにより、収容空間１ｂが収容空間１ａと連通され、円筒壁１４内の収容空間１ａから円筒壁１６内の収容空間１ｂへ薬剤担持体Ｂが移動可能となる。 As described above, the sealing sheet 18 at least partially broken by the breaking claw 17 is largely broken as shown in FIG. 6 by being pressed by the drug carrier B in the housing space 1a. Thus, the storage space 1b is communicated with the storage space 1a, and the drug carrier B can be moved from the storage space 1a in the cylindrical wall 14 to the storage space 1b in the cylindrical wall 16.
この状態で、容器２に振動が加えられると、薬剤担持体Ｂが収容空間１内を自由に移動して、薬剤担持体Ｂ同士、或いは円筒壁１４、１６の内面と衝突し、マイクロカプセルが破袋する。これにより、樹脂ケース２ｂの揮散孔２ｃを介して薬剤Ｙの揮散が開始される。 In this state, when vibration is applied to the container 2, the drug carrier B freely moves in the storage space 1 and collides with each other of the drug carriers B or with the inner surfaces of the cylindrical walls 14 and 16, and the microcapsules Break the bag. Thereby, volatilization of the medicine Y is started via the volatilization hole 2c of the resin case 2b.
このような薬剤担持体Ｂの移動は、円筒壁１６を円筒壁１４の内側に差し込んで収容空間１ａより容積の大きい収容空間１を形成することで可能となる。言い換えると、円筒壁１４の中に薬剤担持体Ｂが収容されて密封シート１８で密封された状態では、薬剤担持体Ｂは自由に動くことができないが、密封シート１８を破封して収容空間１ｂを収容空間１ａに連通して収容空間１の容積を大きくすることで薬剤担持体Ｂが移動可能な空間を広げることができる。 Such movement of the drug carrier B is made possible by inserting the cylindrical wall 16 into the inside of the cylindrical wall 14 to form the containing space 1 having a larger volume than the containing space 1 a. In other words, in the state where the drug carrier B is housed in the cylindrical wall 14 and sealed by the sealing sheet 18, the drug carrier B can not move freely, but the sealing sheet 18 is torn away to accommodate the housing space. By connecting the space 1b to the storage space 1a to increase the volume of the storage space 1, the space in which the drug carrier B can move can be expanded.
また、収容空間１ｂを収容空間１ａに連通させることで、収容空間１ａを揮散孔２ｃに連通させることができ、薬剤Ｙの揮散が可能となる。言い換えると、収容空間１ｂを収容空間１ａに連通させない状態では、収容空間１ａが外気と連絡していないため、薬剤Ｙを揮散させることができない。つまり、本実施形態によると、薬剤揮散具１０の使用開始前の状態（図４に示す状態）においては、薬剤Ｙが揮散する心配が無く、図６に示すように密封シート１８を破封して初めて薬剤Ｙの揮散が可能となり、所望するタイミングで薬剤Ｙの揮散を開始させることができる。このため、薬剤揮散具１０の使用開始時に使用者が薬剤担持体Ｂに担持された薬剤Ｙに触れたり、薬剤担持体Ｂを容器２外に落下させるといった不具合を防止することができる。 Further, by connecting the storage space 1b to the storage space 1a, the storage space 1a can be communicated to the volatilization hole 2c, and the drug Y can be volatilized. In other words, when the accommodation space 1b is not communicated with the accommodation space 1a, the medicine Y can not be volatilized because the accommodation space 1a does not communicate with the outside air. That is, according to the present embodiment, in the state before the start of use of the drug volatilization tool 10 (the state shown in FIG. 4), there is no concern that the drug Y is volatilized, and the sealing sheet 18 is broken as shown in FIG. For the first time, volatilization of the drug Y becomes possible, and volatilization of the drug Y can be started at a desired timing. For this reason, it is possible to prevent problems such as the user touching the drug Y carried on the drug carrier B at the start of use of the drug volatilization tool 10 or dropping the drug carrier B out of the container 2.
以上のように、本実施形態によると、密封シート１８を破封することで薬剤担持体Ｂの移動空間を広げて薬剤Ｙの揮散を可能にした。このため、薬剤Ｙを多く揮散させたい場合には、容器２を振ればよく、所望するタイミングで所望する量の薬剤Ｙを揮散させることができる。また、例えば、本実施形態の薬剤揮散具１０を自動車に取り付けて使用した場合、運転中は自動車の振動により薬剤Ｙを揮散させ、駐車している状態では薬剤Ｙの揮散を止めさせることもでき、容器２をわざわざ振る必要もない。 As described above, according to the present embodiment, the sealing sheet 18 is ruptured to widen the transfer space of the drug carrier B, and the drug Y can be volatilized. Therefore, when it is desired to volatilize a large amount of the drug Y, the container 2 may be shaken, and a desired amount of the drug Y can be volatilized at a desired timing. In addition, for example, when the drug volatilization tool 10 of the present embodiment is attached to a car and used, the medicine Y can be volatilized by vibration of the car during driving, and the volatilization of the medicine Y can be stopped in a parked state. There is no need to shake container 2 on purpose.
（変形例）
以下、上述した第１の実施形態の変形例について図７および図８を参照して説明する。変形例に係る薬剤揮散具は、破封爪（破封部、突起）の形状が異なる以外、上述した第１の実施形態の薬剤揮散具１０と同じ構造を有する。よって、ここでは、第１の実施形態と異なる破封爪の形状について詳細に説明し、それ以外の構造についての説明を省略する。
(Modification)
Hereinafter, a modification of the first embodiment described above will be described with reference to FIGS. 7 and 8. The drug volatilization tool according to the modification has the same structure as the drug volatilization tool 10 of the first embodiment described above except that the shape of the seal claw (the seal portion, the protrusion) is different. Therefore, here, the shape of the tear-off claw different from that of the first embodiment will be described in detail, and the description of the other structures will be omitted.
第１の変形例に係る破封爪２１は、図７に示すように、円筒壁１６をその軸と直交する面に対して傾斜した架空の切断面で切断した形状を有する。このように、円筒体を斜めに切断することで、円筒体の周部の一か所に先鋭な突起を設けることができる。突起をより尖らせたい場合には、切断面の傾斜を大きくすればよい。 As shown in FIG. 7, the tearing-off claw 21 according to the first modification has a shape obtained by cutting the cylindrical wall 16 at an imaginary cut surface inclined with respect to a plane orthogonal to the axis. As described above, by cutting the cylindrical body obliquely, sharp projections can be provided at one portion of the peripheral portion of the cylindrical body. If it is desired to make the projection sharper, the inclination of the cutting surface may be increased.
第２の変形例に係る破封爪３１は、図８に示すように、円筒壁１６の開口部１６ａを設けた先端に、周方向に等間隔で並んで先鋭な突起を複数設けた形状を有する。このように、微小な突起を円筒壁１６の全周に設けることで、密封シート１８の略全周を切り離すことができ、収容空間１ａ、１ｂを容易に連通させることができる。 As shown in FIG. 8, the tear-off claw 31 according to the second modification has a shape in which a plurality of sharp protrusions are provided at equal intervals in the circumferential direction at the tip of the cylindrical wall 16 provided with the opening 16a. Have. As described above, by providing the minute projections around the entire circumference of the cylindrical wall 16, substantially the entire circumference of the sealing sheet 18 can be separated, and the storage spaces 1a and 1b can be easily communicated.
（第２の実施形態）
上述した第１の実施形態では、連結部材８を介して２つの樹脂ケース２ａ、２ｂを連結して、連結部材８を介して一方の樹脂ケース２ｂを樹脂ケース２ａに向けて回動して両者を嵌合させるようにしたが、連結部材８を設けずに２つの樹脂ケース２ａ、２ｂをネジにより螺合させてもよい。
Second Embodiment
In the first embodiment described above, the two resin cases 2a and 2b are connected via the connecting member 8, and one resin case 2b is rotated toward the resin case 2a via the connecting member 8 However, the two resin cases 2a and 2b may be screwed together with a screw without providing the connecting member 8.
図９は、第２の実施形態に係る薬剤揮散具の一方の容器２の２つの樹脂ケース２ａ、２ｂを分離した状態を示す斜視図である。第２の実施形態に係る薬剤揮散具は、２つの樹脂ケース２ａ、２ｂを連結した連結部材８、３つのボス部３、および３本の嵌合ピン５を有しておらず、樹脂ケース２ａの開口部の内縁に雌ネジ４１を有するとともに、樹脂ケース２ｂの開口部の外縁に雌ネジ４１と螺合する雄ネジ４２を有する。これ例外の構成は、上述した第１の実施形態と略同じであるため、ここでは第１の実施形態の薬剤揮散具１０と同様に機能する構成要素には同一符号を付してその詳細な説明を省略する。 FIG. 9 is a perspective view showing a state in which the two resin cases 2a and 2b of one container 2 of the medicine volatilization device according to the second embodiment are separated. The drug volatilization tool according to the second embodiment does not have the connecting member 8 connecting the two resin cases 2a and 2b, the three bosses 3, and the three fitting pins 5, and the resin case 2a The female screw 41 is provided at the inner edge of the opening, and the male screw 42 screwed with the female screw 41 is provided at the outer edge of the opening of the resin case 2b. Since the configuration of this exception is substantially the same as that of the first embodiment described above, components that function in the same manner as the drug volatilization device 10 of the first embodiment will be assigned the same reference numerals and detailed I omit explanation.
本実施形態によると、２つの樹脂ケース２ａ、２ｂを螺合させることで、円筒壁１６の破封爪１７を密封シート１８に突き刺しつつ回転させることができ、密封シート１８を完全に円筒壁１６と切り離すことができ、収容空間１ａ、１ｂを完全に連通させることができる。 According to the present embodiment, by screwing the two resin cases 2a and 2b, the tear-off claws 17 of the cylindrical wall 16 can be rotated while piercing the sealing sheet 18, and the sealing sheet 18 is completely cylindrical wall 16 And the housing spaces 1a and 1b can be completely communicated with each other.
また、本実施形態によると、連結部材８を有していないため、２つの樹脂ケース２ａ、２ｂを嵌合させる際に円筒壁１４、１６の干渉を気にする必要がなく、円筒壁１４の高さを第１の実施形態より高くすることができる。これにより、薬剤担持体Ｂを収容する収容空間１ａを大きくすることができ、より多くの薬剤担持体Ｂを収容することができる。 Further, according to the present embodiment, since the connecting member 8 is not provided, there is no need to worry about the interference of the cylindrical walls 14 and 16 when fitting the two resin cases 2a and 2b. The height can be higher than in the first embodiment. Thereby, the accommodation space 1a which accommodates the medicine carrier B can be enlarged, and more medicine carriers B can be accommodated.
以上、いくつかの実施形態に基づいて本発明を説明したが、本発明は、上述した実施形態に限定されるものではなく、本発明の要旨の範囲内で種々の変形や応用が可能なことは勿論である。 As mentioned above, although this invention was demonstrated based on some embodiment, this invention is not limited to embodiment mentioned above, A various deformation | transformation and application are possible within the range of the summary of this invention. Of course.
１、１ａ、１ｂ…収容空間、 ２、４…容器、 ２ａ、２ｂ…樹脂ケース、 ２ｃ…揮散孔、 ６…ゴム紐、 １０…薬剤揮散具、 １４、１６…円筒壁、 １４ａ、１６ａ…開口部、 １７、２１、３１…破封爪、 １８…密封シート、 ４１…雌ネジ、 ４２…雄ネジ、 Ｂ…薬剤担持体、 Ｙ…薬剤。 DESCRIPTION OF SYMBOLS 1, 1a, 1b ... Accommodation space 2, 4 ... Container, 2a, 2b ... Resin case, 2c ... Volatilization hole, 6 ... Rubber string, 10 ... Chemical volatilization tool, 14 and 16 ... Cylindrical wall, 14a, 16a ... Opening Parts 17, 21, 31 ... tear-off nails, 18 ... sealing sheet, 41 ... female screw, 42 ... male screw, B ... drug carrier, Y ... drug.
Claims (7)
前記第１の収容部の前記第１の開口部を封止して前記第１の空間を密封した密封材と、
前記薬剤担持体を受け入れ可能な第２の空間、前記第２の空間を前記第１の収容部の前記第１の空間に連通させるための第２の開口部、前記第２の開口部に設けられ前記第２の開口部を前記第１の開口部に重ねたときに前記第１の開口部の内側に挿通されて前記密封材を破る破封部、および前記第２の空間を外気に連通させるための揮散孔を有する第２の収容部と、
を有する薬剤揮散具。 A first space containing a drug carrier carrying a drug having a volatile property, and a first container having a first opening for opening the first space;
A sealing material that seals the first space by sealing the first opening of the first housing portion;
A second space capable of receiving the drug carrier, a second opening for communicating the second space to the first space of the first storage portion, and the second opening are provided. And a tear-off portion which is inserted into the inside of the first opening when the second opening is overlapped with the first opening to break the sealing material, and the second space is communicated with the outside air A second housing portion having a volatilization hole for
Drug volatilizer with.
前記第２の収容部は、前記第２の開口部を一端に有する有底の筒状体であり、
前記破封部は、前記筒状体の前記一端を軸方向に突出させた突起であり、前記第１の収容部の前記第１の開口部の内側に挿入される、
請求項１の薬剤揮散具。 The second opening has a smaller diameter than the first opening,
The second housing portion is a bottomed cylindrical body having the second opening at one end,
The seal portion is a projection in which the one end of the cylindrical body is axially protruded, and the seal portion is inserted inside the first opening of the first accommodation portion.
The drug volatilization device of claim 1.
請求項１の薬剤揮散具。 In the state where the first space of the first accommodation portion accommodates a predetermined number of the drug carriers and the first opening is sealed by the sealing material, the drug carrier is the first space. Have a volume that can not move freely in the space of
The drug volatilization device of claim 1.
請求項２の薬剤揮散具。 The projection has a shape obtained by cutting the cylindrical body at an imaginary cutting plane inclined with respect to a plane orthogonal to the axis thereof.
The drug volatilization device of claim 2.
請求項２の薬剤揮散具。 A plurality of the protrusions are provided along the circumferential direction of the one end of the cylindrical body.
The drug volatilization device of claim 2.
前記第２の収容部の外側に当該第２の収容部と一体に設けた前記第１のケースと嵌合する第２のケースと、
前記第１のケースと前記第２のケースを一体に連結した可撓性を有する連結部材と、
をさらに有する請求項１の薬剤揮散具。 A first case provided integrally with the first accommodating portion outside the first accommodating portion;
A second case fitted with the first case provided integrally with the second housing outside the second housing;
A flexible connecting member integrally connecting the first case and the second case;
The drug volatilizer according to claim 1, further comprising
前記第２の収容部の外側に当該第２の収容部と一体に設けた前記第１のケースと螺合する第２のケースと、をさらに有し、
前記第１のケースと前記第２のケースを螺合することで前記破封部が前記第１の開口部に挿通されつつ回転される、
請求項１の薬剤揮散具。 A first case provided integrally with the first accommodating portion outside the first accommodating portion;
And a second case screwed with the first case integrally provided on the outside of the second housing portion with the second housing portion,
By screwing the first case and the second case, the seal portion is rotated while being inserted into the first opening.
The drug volatilization device of claim 1.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2017188431A JP7126815B2 (en) | 2017-09-28 | 2017-09-28 | chemical volatilizer |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2017188431A JP7126815B2 (en) | 2017-09-28 | 2017-09-28 | chemical volatilizer |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2019064597A true JP2019064597A (en) | 2019-04-25 |
| JP7126815B2 JP7126815B2 (en) | 2022-08-29 |
Family
ID=66338397
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017188431A Active JP7126815B2 (en) | 2017-09-28 | 2017-09-28 | chemical volatilizer |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP7126815B2 (en) |
Citations (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS61190449A (en) * | 1985-02-06 | 1986-08-25 | センツ オブ ヘヴン，インコ−ポレ−テツド | Balloon containing perfume and valve |
| JPS62129057A (en) * | 1985-11-29 | 1987-06-11 | カネボウ株式会社 | Heating type aroma apparatus |
| JPH10204955A (en) * | 1997-01-27 | 1998-08-04 | Johnson Co Ltd | Washing aromatic vessel for water closet |
| JP2008289755A (en) * | 2007-05-28 | 2008-12-04 | Dainippon Printing Co Ltd | Medicine vaporizer |
| JP2010083498A (en) * | 2008-09-30 | 2010-04-15 | Yoshino Kogyosho Co Ltd | Refilling container |
| JP2011025941A (en) * | 2009-07-22 | 2011-02-10 | Toppan Printing Co Ltd | Medicine storage container, and package using the same |
| JP2014195570A (en) * | 2013-03-29 | 2014-10-16 | 株式会社吉野工業所 | Volatilizing agent container |
| JP2015139401A (en) * | 2014-01-28 | 2015-08-03 | 株式会社イケックス | Fruit protector |
| JP2017121973A (en) * | 2017-03-10 | 2017-07-13 | 株式会社吉野工業所 | Method for producing lid member made from synthetic resin |
-
2017
- 2017-09-28 JP JP2017188431A patent/JP7126815B2/en active Active
Patent Citations (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS61190449A (en) * | 1985-02-06 | 1986-08-25 | センツ オブ ヘヴン，インコ−ポレ−テツド | Balloon containing perfume and valve |
| JPS62129057A (en) * | 1985-11-29 | 1987-06-11 | カネボウ株式会社 | Heating type aroma apparatus |
| JPH10204955A (en) * | 1997-01-27 | 1998-08-04 | Johnson Co Ltd | Washing aromatic vessel for water closet |
| JP2008289755A (en) * | 2007-05-28 | 2008-12-04 | Dainippon Printing Co Ltd | Medicine vaporizer |
| JP2010083498A (en) * | 2008-09-30 | 2010-04-15 | Yoshino Kogyosho Co Ltd | Refilling container |
| JP2011025941A (en) * | 2009-07-22 | 2011-02-10 | Toppan Printing Co Ltd | Medicine storage container, and package using the same |
| JP2014195570A (en) * | 2013-03-29 | 2014-10-16 | 株式会社吉野工業所 | Volatilizing agent container |
| JP2015139401A (en) * | 2014-01-28 | 2015-08-03 | 株式会社イケックス | Fruit protector |
| JP2017121973A (en) * | 2017-03-10 | 2017-07-13 | 株式会社吉野工業所 | Method for producing lid member made from synthetic resin |
Also Published As
| Publication number | Publication date |
|---|---|
| JP7126815B2 (en) | 2022-08-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2296155T3 (en) | CEBO STATIONS. | |
| JP2008030846A (en) | Container | |
| ES2487655T3 (en) | Volatile material dispenser and method of holding a recharge or refills to it | |
| JP2019064597A (en) | Chemical volatilizer | |
| JP2003528775A (en) | Fluid container and related improvements | |
| JP4823683B2 (en) | Volatilizer | |
| JP6896412B2 (en) | Volatilizer | |
| JP5320148B2 (en) | Air freshener container body | |
| WO2021261335A1 (en) | Chemical solution volatilizer | |
| JP7027093B2 (en) | Chemical volatilizer | |
| JP6786319B2 (en) | Chemical volatilizer | |
| JP2019058092A (en) | Chemical volatilization device | |
| JP6804950B2 (en) | Volatilizer | |
| JP2005261805A (en) | Liquid aromatic container | |
| WO2021204081A1 (en) | Fragrance liquid container | |
| JP2005058338A (en) | Volatilization apparatus, outer container for volatilization apparatus and storage container | |
| JP5969839B2 (en) | Volatilization container | |
| JP4817163B2 (en) | Air freshener container | |
| JP7383379B2 (en) | Chemical volatilizer | |
| US12004629B2 (en) | Diffuser of volatile liquid substances equipped with a vapor permeable membrane, activated at the time of use | |
| JP7319176B2 (en) | chemical volatilizer | |
| JP5205080B2 (en) | Vaporized chemical storage container | |
| JP2016049988A (en) | Volatilization container | |
| JP3003209U (en) | Drug storage container | |
| JP4903939B2 (en) | Drug container for fan-type drug diffusion device |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20200805 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20210628 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20210713 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20210913 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20220118 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20220322 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20220719 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20220817 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 7126815 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |